Retraction notice to "Blockade of CD73 using siRNA loaded chitosan lactate nanoparticles functionalized with TAT-hyaluronate enhances doxorubicin mediated cytotoxicity in cancer cells both in vitro and in vivo" [Int. J. Biol. Macromol. 186 (2021) 849-863]

Affiliations

¹ Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Biochemistry, Faculty of Materials Engineering, Islamic Azad University, Najafabad Branch, Najafabad, Iran.
² Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
³ Medical Biology Research Center, Health Technologies Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.
⁴ Finance University under the Government of the Russian Federation, Moscow, Russian Federation.
⁵ Department of Prosthetic Dentistry, Sechenov First Moscow State Medical University, Moscow, Russia.
⁶ Department of Biology, Faculty of Sciences, Golestan University, Gorgan, Iran.
⁷ Bioclinicum, Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden.
⁸ Department of Pharmacology and Toxicology, Faculty of Pharmacy, Urmia University of Medical Sciences, Urmia, Iran; Experimental and Applied Pharmaceutical Sciences Research Center, Urmia University of Medical Sciences, Urmia, Iran.
⁹ Department of Anesthesiology, School of Medicine, Imam Reza Medical Research & Training Hospital, Tabriz University of Medical Sciences, Tabriz, Iran.
¹⁰ Immunogenetic Research Center, Mazandaran University of Medical Sciences, Sari, Iran.
¹¹ Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
¹² Solid Tumor Research Center, Cellular and Medicine Research Institute, Urmia University of Medical Sciences, Urmia, Iran. Electronic address: jafari.reza@umsu.ac.ir.
¹³ Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: jadidif@tbzmed.ac.ir.

PMID: 40774891
DOI: 10.1016/j.ijbiomac.2025.146069

Retraction notice to "Blockade of CD73 using siRNA loaded chitosan lactate nanoparticles functionalized with TAT-hyaluronate enhances doxorubicin mediated cytotoxicity in cancer cells both in vitro and in vivo" [Int. J. Biol. Macromol. 186 (2021) 849-863]

Armin Mahmoud Salehi Khesht et al. Int J Biol Macromol. 2025 Aug.

. 2025 Aug;320(Pt 2):146069.

doi: 10.1016/j.ijbiomac.2025.146069. Epub 2025 Aug 6.

Affiliations

¹ Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Biochemistry, Faculty of Materials Engineering, Islamic Azad University, Najafabad Branch, Najafabad, Iran.
² Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
³ Medical Biology Research Center, Health Technologies Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.
⁴ Finance University under the Government of the Russian Federation, Moscow, Russian Federation.
⁵ Department of Prosthetic Dentistry, Sechenov First Moscow State Medical University, Moscow, Russia.
⁶ Department of Biology, Faculty of Sciences, Golestan University, Gorgan, Iran.
⁷ Bioclinicum, Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden.
⁸ Department of Pharmacology and Toxicology, Faculty of Pharmacy, Urmia University of Medical Sciences, Urmia, Iran; Experimental and Applied Pharmaceutical Sciences Research Center, Urmia University of Medical Sciences, Urmia, Iran.
⁹ Department of Anesthesiology, School of Medicine, Imam Reza Medical Research & Training Hospital, Tabriz University of Medical Sciences, Tabriz, Iran.
¹⁰ Immunogenetic Research Center, Mazandaran University of Medical Sciences, Sari, Iran.
¹¹ Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
¹² Solid Tumor Research Center, Cellular and Medicine Research Institute, Urmia University of Medical Sciences, Urmia, Iran. Electronic address: jafari.reza@umsu.ac.ir.
¹³ Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: jadidif@tbzmed.ac.ir.

PMID: 40774891
DOI: 10.1016/j.ijbiomac.2025.146069

No abstract available

PubMed Disclaimer

Retraction of

Blockade of CD73 using siRNA loaded chitosan lactate nanoparticles functionalized with TAT-hyaluronate enhances doxorubicin mediated cytotoxicity in cancer cells both in vitro and in vivo.
Salehi Khesht AM, Karpisheh V, Sahami Gilan P, Melnikova LA, Olegovna Zekiy A, Mohammadi M, Hojjat-Farsangi M, Majidi Zolbanin N, Mahmoodpoor A, Hassannia H, Aghebati-Maleki L, Jafari R, Jadidi-Niaragh F. Salehi Khesht AM, et al. Int J Biol Macromol. 2021 Sep 1;186:849-863. doi: 10.1016/j.ijbiomac.2021.07.034. Epub 2021 Jul 7. Int J Biol Macromol. 2021. Retraction in: Int J Biol Macromol. 2025 Aug;320(Pt 2):146069. doi: 10.1016/j.ijbiomac.2025.146069. PMID: 34245737 Retracted.

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Retraction notice to "Blockade of CD73 using siRNA loaded chitosan lactate nanoparticles functionalized with TAT-hyaluronate enhances doxorubicin mediated cytotoxicity in cancer cells both in vitro and in vivo" [Int. J. Biol. Macromol. 186 (2021) 849-863]

Affiliations

Retraction notice to "Blockade of CD73 using siRNA loaded chitosan lactate nanoparticles functionalized with TAT-hyaluronate enhances doxorubicin mediated cytotoxicity in cancer cells both in vitro and in vivo" [Int. J. Biol. Macromol. 186 (2021) 849-863]

Authors

Affiliations

Retraction of

References

Publication types

LinkOut - more resources

Full Text Sources

Research Materials